Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Galectin Therapeutics Price to Sales Ratio 2010-2023 | GALT

Historical PS ratio values for Galectin Therapeutics (GALT) over the last 10 years. The current P/S ratio for Galectin Therapeutics as of April 15, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Galectin Therapeutics P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-04-15 3.91 inf
2023-09-30 1.92 0 0.00
2023-06-30 1.44 0 0.00
2023-03-31 2.10 0 0.00
2022-12-31 1.13 0 0.00
2022-09-30 1.63 0 0.00
2022-06-30 1.31 0 0.00
2022-03-31 1.61 0 0.00
2021-12-31 2.07 0 0.00
2021-09-30 3.88 0 0.00
2021-06-30 3.20 0 0.00
2021-03-31 2.17 0 0.00
2020-12-31 2.24 0 0.00
2020-09-30 2.67 0 0.00
2020-06-30 3.06 0 0.00
2020-03-31 1.96 0 0.00
2019-12-31 2.86 0 0.00
2019-09-30 3.67 0 0.00
2019-06-30 4.15 0 0.00
2019-03-31 5.11 0 0.00
2018-12-31 3.43 0 0.00
2018-09-30 6.01 0 0.00
2018-06-30 6.36 0 0.00
2018-03-31 4.74 0 0.00
2017-12-31 3.34 0 0.00
2017-09-30 2.14 0 0.00
2017-06-30 2.46 0 0.00
2017-03-31 2.30 0 0.00
2016-12-31 0.98 0 0.00
2016-09-30 1.13 0 0.00
2016-06-30 1.47 0 0.00
2016-03-31 1.43 0 0.00
2015-12-31 1.64 0 0.00
2015-09-30 2.34 0 0.00
2015-06-30 2.73 0 0.00
2015-03-31 3.35 0 0.00
2014-12-31 3.47 0 0.00
2014-09-30 5.03 0 0.00
2014-06-30 13.81 0 0.00
2014-03-31 15.31 0 0.00
2013-12-31 8.08 0 0.00
2013-09-30 9.97 0 0.00
2013-06-30 4.25 0 0.00
2013-03-31 3.59 0 0.00
2012-12-31 2.05 0 0.00
2012-09-30 2.23 0 0.00
2012-06-30 2.05 0 0.00
2012-03-31 4.04 0 0.00
2011-12-31 5.76 0 0.00
2011-09-30 5.16 0 0.00
2011-06-30 7.32 0 0.00
2011-03-31 6.24 0 0.00
2010-12-31 5.40 0 0.00
2010-09-30 4.74 0 0.00
2010-06-30 4.28 0 0.00
2010-03-31 2.64 0 0.00
2009-12-31 1.68 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.246B $0.000B
Galectin Therapeutics Inc. is a drug development company engaged in the development new therapies for fibrotic disease and cancer. The Company uses its carbohydrate technology that targets galectin proteins, the key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Galectin Therapeutics, formerly known as Pro-Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.595B 28.19
Chugai Pharmaceutical (CHGCY) Japan $54.482B 23.66
Takeda Pharmaceutical (TAK) Japan $42.314B 6.86
Merck (MKGAF) Germany $21.132B 19.94
Astellas Pharma (ALPMY) Japan $17.282B 24.49
Shionogi (SGIOY) Japan $14.459B 12.51
Neurocrine Biosciences (NBIX) United States $13.400B 55.65
Sandoz Group AG (SDZNY) $12.650B 0.00
United Therapeutics (UTHR) United States $10.945B 11.72
Catalent (CTLT) United States $10.176B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.599B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.967B 7.07
Ionis Pharmaceuticals (IONS) United States $6.084B 0.00
Revolution Medicines (RVMD) United States $5.940B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.341B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Madrigal Pharmaceuticals (MDGL) United States $4.708B 0.00
Alpine Immune Sciences (ALPN) United States $4.219B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.103B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.060B 0.00
Indivior (INDV) United States $2.664B 12.39
Evotec AG (EVO) Germany $2.583B 0.00
Summit Therapeutics (SMMT) United States $2.572B 0.00
Corcept Therapeutics (CORT) United States $2.434B 24.75
Dyne Therapeutics (DYN) United States $2.228B 0.00
PTC Therapeutics (PTCT) United States $2.024B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.973B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.796B 18.56
NewAmsterdam Pharma (NAMS) Netherlands $1.759B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.695B 10.04
Ardelyx (ARDX) United States $1.643B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.580B 27.66
Avadel Pharmaceuticals (AVDL) Ireland $1.448B 0.00
4D Molecular Therapeutics (FDMT) United States $1.348B 0.00
Xencor (XNCR) United States $1.252B 0.00
Pacira BioSciences (PCRX) United States $1.248B 12.42
Ironwood Pharmaceuticals (IRWD) United States $1.233B 11.59
Soleno Therapeutics (SLNO) United States $1.206B 0.00
Ocular Therapeutix (OCUL) United States $1.188B 0.00
Collegium Pharmaceutical (COLL) United States $1.168B 7.19
Centessa Pharmaceuticals (CNTA) United Kingdom $1.135B 0.00
Cassava Sciences (SAVA) United States $0.984B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.983B 0.00
Cronos Group (CRON) Canada $0.959B 0.00
Sage Therapeutics (SAGE) United States $0.928B 0.00
Relay Therapeutics (RLAY) United States $0.922B 0.00
ARS Pharmaceuticals (SPRY) United States $0.870B 0.00
Enliven Therapeutics (ELVN) United States $0.869B 0.00
USANA Health Sciences (USNA) United States $0.846B 13.32
Lyell Immunopharma (LYEL) United States $0.765B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.738B 0.00
Savara (SVRA) United States $0.700B 0.00
Silence Therapeutics (SLN) United Kingdom $0.664B 0.00
Verve Therapeutics (VERV) United States $0.636B 0.00
Siga Technologies (SIGA) United States $0.626B 9.27
Korro Bio (KRRO) United States $0.601B 0.00
OmniAb (OABI) United States $0.591B 0.00
Altimmune (ALT) United States $0.566B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.566B 0.00
Exscientia (EXAI) United Kingdom $0.563B 0.00
Tourmaline Bio (TRML) United States $0.517B 0.00
KalVista Pharmaceuticals (KALV) United States $0.502B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.467B 0.00
Harrow (HROW) United States $0.447B 0.00
Larimar Therapeutics (LRMR) United States $0.444B 0.00
Heron Therapeutics (HRTX) United States $0.437B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.429B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.413B 0.00
Esperion Therapeutics (ESPR) United States $0.405B 0.00
Lexeo Therapeutics (LXEO) United States $0.403B 0.00
ProKidney (PROK) United States $0.401B 0.00
Organogenesis (ORGO) United States $0.380B 72.00
Bioventus (BVS) United States $0.362B 0.00
Nature's Sunshine Products (NATR) United States $0.358B 20.02
Enanta Pharmaceuticals (ENTA) United States $0.348B 0.00
ESSA Pharma (EPIX) Canada $0.343B 0.00
Metagenomi (MGX) United States $0.336B 0.00
Foghorn Therapeutics (FHTX) United States $0.316B 0.00
Lyra Therapeutics (LYRA) United States $0.315B 0.00
Fractyl Health (GUTS) United States $0.312B 0.00
Prelude Therapeutics (PRLD) United States $0.309B 0.00
Nektar Therapeutics (NKTR) United States $0.307B 0.00
Akebia Therapeutics (AKBA) United States $0.306B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Nanobiotix S.A (NBTX) France $0.287B 0.00
Aquestive Therapeutics (AQST) United States $0.287B 0.00
Pyxis Oncology (PYXS) United States $0.286B 0.00
Adherex Technologies (FENC) United States $0.284B 0.00
Black Diamond Therapeutics (BDTX) United States $0.271B 0.00
Xeris Biopharma Holdings (XERS) United States $0.268B 0.00
Telomir Pharmaceuticals (TELO) United States $0.266B 0.00
Avita Medical (RCEL) United States $0.254B 0.00
Century Therapeutics (IPSC) United States $0.253B 0.00
Aldeyra Therapeutics (ALDX) United States $0.250B 0.00
Conduit Pharmaceuticals (CDT) United States $0.232B 0.00
Acrivon Therapeutics (ACRV) United States $0.226B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.210B 0.00
Zevra Therapeutics (ZVRA) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.193B 0.00
Incannex Healthcare (IXHL) Australia $0.189B 0.00
Regulus Therapeutics (RGLS) United States $0.183B 0.00
VAXART, INC (VXRT) United States $0.158B 0.00
CytoDyn (CYDY) United States $0.156B 0.00
GlycoMimetics (GLYC) United States $0.155B 0.00
Inotiv (NOTV) United States $0.154B 0.00
MediWound (MDWD) Israel $0.152B 0.00
Elite Pharmaceuticals (ELTP) United States $0.150B 14.00
Achieve Life Sciences (ACHV) Canada $0.149B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.142B 3.00
Karyopharm Therapeutics (KPTI) United States $0.140B 0.00
Relmada Therapeutics (RLMD) United States $0.140B 0.00
OptiNose (OPTN) United States $0.137B 0.00
FibroGen (FGEN) United States $0.128B 0.00
Cardiol Therapeutics (CRDL) Canada $0.127B 0.00
Citius Pharmaceuticals (CTXR) United States $0.125B 0.00
Eliem Therapeutics (ELYM) United States $0.119B 0.00
ProPhase Labs (PRPH) United States $0.118B 0.00
Vivani Medical (VANI) United States $0.114B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.103B 0.00
PMV Pharmaceuticals (PMVP) United States $0.092B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Journey Medical (DERM) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.68
Carisma Therapeutics (CARM) United States $0.080B 0.00
Tempest Therapeutics (TPST) United States $0.080B 0.00
Mural Oncology (MURA) $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.057B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.81
Gain Therapeutics (GANX) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Viracta Therapeutics (VIRX) United States $0.045B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.035B 0.00
Nutriband (NTRB) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
Lipocine (LPCN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Aptorum Group (APM) United Kingdom $0.029B 0.00
Addex Therapeutics (ADXN) Switzerland $0.027B 0.00
CERo Therapeutics Holdings (CERO) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Alaunos Therapeutics (TCRT) United States $0.026B 0.00
JanOne (JAN) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
DURECT (DRRX) United States $0.024B 0.00
Indaptus Therapeutics (INDP) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.87
TherapeuticsMD (TXMD) United States $0.023B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Surrozen (SRZN) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.10
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Biomerica (BMRA) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Clever Leaves Holdings (CLVR) Canada $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
XORTX Therapeutics (XRTX) Canada $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Petros Pharmaceuticals (PTPI) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.17
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 47.40